Published in Mol Imaging on February 01, 2012
Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed (2013) 1.88
Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI. Magn Reson Med (2013) 1.48
Detection of in vivo enzyme activity with CatalyCEST MRI. Magn Reson Med (2014) 1.00
The Hanes-Woolf linear QUESP method improves the measurements of fast chemical exchange rates with CEST MRI. Magn Reson Med (2013) 0.99
A review of responsive MRI contrast agents: 2005-2014. Contrast Media Mol Imaging (2014) 0.98
Measuring extracellular pH in a lung fibrosis model with acidoCEST MRI. Mol Imaging Biol (2015) 0.98
A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma. Nanomedicine (Lond) (2012) 0.97
Evaluations of Tumor Acidosis Within In Vivo Tumor Models Using Parametric Maps Generated with Acido CEST MRI. Mol Imaging Biol (2015) 0.94
Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI. Mol Imaging Biol (2014) 0.93
Overcoming the concentration-dependence of responsive probes for magnetic resonance imaging. Metallomics (2015) 0.91
The reciprocal linear QUEST analysis method facilitates the measurements of chemical exchange rates with CEST MRI. Contrast Media Mol Imaging (2014) 0.91
Anthranilic acid analogs as diamagnetic CEST MRI contrast agents that feature an intramolecular-bond shifted hydrogen. Contrast Media Mol Imaging (2014) 0.88
NOrmalized MAgnetization Ratio (NOMAR) filtering for creation of tissue selective contrast maps. Magn Reson Med (2012) 0.86
Imaging of endogenous exchangeable proton signals in the human brain using frequency labeled exchange transfer imaging. Magn Reson Med (2013) 0.84
Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models. Leuk Lymphoma (2014) 0.84
Quantification of iopamidol multi-site chemical exchange properties for ratiometric chemical exchange saturation transfer (CEST) imaging of pH. Phys Med Biol (2014) 0.84
Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobe. Contrast Media Mol Imaging (2015) 0.84
Structural optimization of Zn(II)-activated magnetic resonance imaging probes. Inorg Chem (2013) 0.83
Quantitative description of radiofrequency (RF) power-based ratiometric chemical exchange saturation transfer (CEST) pH imaging. NMR Biomed (2015) 0.81
High-field small animal magnetic resonance oncology studies. Phys Med Biol (2013) 0.81
Could magnetic resonance provide in vivo histology? Front Genet (2014) 0.81
The stereochemistry of amide side chains containing carboxyl groups influences water exchange rates in EuDOTA-tetraamide complexes. J Biol Inorg Chem (2013) 0.80
Time domain removal of irrelevant magnetization in chemical exchange saturation transfer Z-spectra. Magn Reson Med (2013) 0.80
Design and testing of paramagnetic liposome-based CEST agents for MRI visualization of payload release on pH-induced and ultrasound stimulation. J Biol Inorg Chem (2013) 0.79
Evaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging Methods. Adv Radiol (2015) 0.78
The effect of regioisomerism on the coordination chemistry and CEST properties of lanthanide(III) NB-DOTA-tetraamide chelates. J Biol Inorg Chem (2013) 0.77
Fast simulation and optimization of pulse-train chemical exchange saturation transfer (CEST) imaging. Phys Med Biol (2015) 0.77
A method for accurate pH mapping with chemical exchange saturation transfer (CEST) MRI. Contrast Media Mol Imaging (2015) 0.76
Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI. Mol Imaging Biol (2016) 0.75
Multislice CEST MRI improves the spatial assessment of tumor pH. Magn Reson Med (2016) 0.75
A new paramagnetically shifted imaging probe for MRI. Magn Reson Med (2016) 0.75
A biomarker-responsive T2ex MRI contrast agent. Magn Reson Med (2016) 0.75
On the origin of cancer cells. Science (1956) 49.55
A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson (2000) 8.73
Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med (2003) 4.57
PARACEST agents: modulating MRI contrast via water proton exchange. Acc Chem Res (2003) 4.44
Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med (2002) 4.03
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Quantitative interpretation of magnetization transfer. Magn Reson Med (1993) 3.55
Hydrogen exchange. Annu Rev Biochem (1972) 3.31
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res (1996) 3.11
MRI of the tumor microenvironment. J Magn Reson Imaging (2002) 2.87
Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med (2004) 2.80
Are cancer cells acidic? Br J Cancer (1991) 2.72
pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag (2004) 2.68
Proton exchange rates from amino acid side chains--implications for image contrast. Magn Reson Med (1996) 2.53
Novel pH-reporter MRI contrast agents. Angew Chem Int Ed Engl (2002) 2.49
Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis (1996) 2.44
A PARACEST MRI contrast agent to detect enzyme activity. J Am Chem Soc (2006) 2.26
Ln(III)-DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications. Invest Radiol (2004) 2.10
Correction for artifacts induced by B(0) and B(1) field inhomogeneities in pH-sensitive chemical exchange saturation transfer (CEST) imaging. Magn Reson Med (2007) 2.09
Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med (2003) 2.05
High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med (2006) 1.97
Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Magn Reson Med (2007) 1.88
Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents. Magn Reson Med (2008) 1.85
A Novel pH-Sensitive MRI Contrast Agent. Angew Chem Int Ed Engl (1999) 1.83
pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc (2001) 1.74
PARACEST MRI with improved temporal resolution. Magn Reson Med (2009) 1.69
Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. Angew Chem Int Ed Engl (2008) 1.58
Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol (2003) 1.57
CEST-FISP: a novel technique for rapid chemical exchange saturation transfer MRI at 7 T. Magn Reson Med (2010) 1.50
Dendritic PARACEST contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging (2007) 1.50
Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene (2001) 1.41
Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents. NMR Biomed (2011) 1.40
Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol (2003) 1.38
Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol Pharm (2009) 1.35
Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. Contrast Media Mol Imaging (2008) 1.35
Clastogenicity of low pH to various cultured mammalian cells. Mutat Res (1992) 1.30
A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity. Contrast Media Mol Imaging (2010) 1.29
Acquisition and interpretation of hydrogen exchange data from peptides, polymers, and proteins. Methods Biochem Anal (1982) 1.06
An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Res (1995) 0.94
The physiological environment in cancer vascularization, invasion and metastasis. Novartis Found Symp (2001) 0.92
Synthesis, characterization, and X-ray crystal structure of In(DOTA-AA) (AA = p-aminoanilide): a model for 111In-labeled DOTA-biomolecule conjugates. Inorg Chem (2003) 0.91
Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med (2004) 6.48
Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies. Acc Chem Res (2009) 1.95
Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Magn Reson Med (2007) 1.88
An overview of responsive MRI contrast agents for molecular imaging. Front Biosci (2008) 1.83
PARACEST MRI with improved temporal resolution. Magn Reson Med (2009) 1.69
Enzyme-responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome. Contrast Media Mol Imaging (2007) 1.58
Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis (2004) 1.49
Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI. Magn Reson Med (2013) 1.48
Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol Pharm (2009) 1.35
Measuring in vivo tumor pHe with CEST-FISP MRI. Magn Reson Med (2011) 1.33
Possible role of aerosol transmission in a hospital outbreak of influenza. Clin Infect Dis (2010) 1.31
Exhaled droplets due to talking and coughing. J R Soc Interface (2009) 1.31
A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity. Contrast Media Mol Imaging (2010) 1.29
Improved pH measurements with a single PARACEST MRI contrast agent. Contrast Media Mol Imaging (2012) 1.28
Transmission of influenza A in human beings. Lancet Infect Dis (2007) 1.13
A catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bond. J Am Chem Soc (2013) 1.01
Detection of in vivo enzyme activity with CatalyCEST MRI. Magn Reson Med (2014) 1.00
Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature. Cancer Res (2004) 0.99
The Hanes-Woolf linear QUESP method improves the measurements of fast chemical exchange rates with CEST MRI. Magn Reson Med (2013) 0.99
Measuring extracellular pH in a lung fibrosis model with acidoCEST MRI. Mol Imaging Biol (2015) 0.98
A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma. Nanomedicine (Lond) (2012) 0.97
Dependence of the cytotoxicity of multi-walled carbon nanotubes on the culture medium. Nanotechnology (2006) 0.94
Role of two-way airflow owing to temperature difference in severe acute respiratory syndrome transmission: revisiting the largest nosocomial severe acute respiratory syndrome outbreak in Hong Kong. J R Soc Interface (2010) 0.94
Evaluations of Tumor Acidosis Within In Vivo Tumor Models Using Parametric Maps Generated with Acido CEST MRI. Mol Imaging Biol (2015) 0.94
An amine-derivatized, DOTA-loaded polymeric support for Fmoc Solid Phase Peptide Synthesis. Tetrahedron Lett (2009) 0.92
The reciprocal linear QUEST analysis method facilitates the measurements of chemical exchange rates with CEST MRI. Contrast Media Mol Imaging (2014) 0.91
Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients. Clin Infect Dis (2005) 0.90
Fluorescent and lanthanide labeling for ligand screens, assays, and imaging. Methods Mol Biol (2011) 0.89
Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model. Magn Reson Imaging (2012) 0.89
Bacterial survival in evaporating deposited droplets on a teflon-coated surface. Appl Microbiol Biotechnol (2006) 0.88
The hope and hype of multimodality imaging contrast agents. Nanomedicine (Lond) (2011) 0.87
Peptidyl molecular imaging contrast agents using a new solid-phase peptide synthesis approach. Bioconjug Chem (2007) 0.87
Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models. Leuk Lymphoma (2014) 0.84
Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI. Magn Reson Med (2013) 0.84
The interaction and toxicity of multi-walled carbon nanotubes with Stylonychia mytilus. J Nanosci Nanotechnol (2006) 0.83
Non-invasive temperature mapping using temperature-responsive water saturation shift referencing (T-WASSR) MRI. NMR Biomed (2014) 0.83
Monitoring infection and inflammation in murine models of cystic fibrosis with magnetic resonance imaging. J Magn Reson Imaging (2008) 0.82
Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy. Sensors (Basel) (2013) 0.81
Multiwalled nanotubes formed by catanionic mixtures of drug amphiphiles. ACS Nano (2014) 0.80
A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents. Magn Reson Imaging (2013) 0.78
Monitoring the development of xenograft triple-negative breast cancer models using diffusion-weighted magnetic resonance imaging. Exp Biol Med (Maywood) (2012) 0.78
Detecting enzyme activities with exogenous MRI contrast agents. Chemistry (2014) 0.78
A linear algorithm of the reference region model for DCE-MRI is robust and relaxes requirements for temporal resolution. Magn Reson Imaging (2012) 0.77
The secret behind the mask. Indoor Air (2011) 0.77
Cytotoxicity of phenol red in toxicity assays for carbon nanoparticles. Int J Mol Sci (2012) 0.77
Anisakiasis in China: the first clinical case report. Foodborne Pathog Dis (2013) 0.77
Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor. Pancreas (2016) 0.77
One-Component Supramolecular Filament Hydrogels as Theranostic Label-Free Magnetic Resonance Imaging Agents. ACS Nano (2017) 0.76
Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging. Exp Biol Med (Maywood) (2014) 0.76
Lanthanide-mediated dephosphorylation used for peptide cleavage during solid phase peptide synthesis. Molecules (2013) 0.75
Indoor Air and infection. Indoor Air (2007) 0.75
The effects of gamma-irradiation dose on chemical modification of multi-walled carbon nanotubes. Nanotechnology (2005) 0.75
Correction to Practical Indicators for Risk of Airborne Transmission in Shared Indoor Environments and Their Application to COVID-19 Outbreaks. Environ Sci Technol (2022) 0.75
On the contribution of mean flow and turbulence to city breathability: the case of long streets with tall buildings. Sci Total Environ (2012) 0.75